DuVall, Adam S.

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Badar, T., Nanaa, A., Atallah, E., Shallis, R. M., Guilherme, S. D. C. C., Goldberg, A. D., Saliba, A. N., Patel, A., Bewersdorf, J. P., DuVall, A. S., et al. (2024) · Blood Cancer Journal

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 33

Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy

Madero-Marroquin, R., Dworkin, E., Weiner, H., Saygin, C., Nawas, M. T., Drazer, M. W., DuVall, A. S., Kosuri, S., Thirman, M. J., Odenike, O., et al. (2024) · Leukemia & Lymphoma

Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research

Cited by 2